Belsky Marc 4
4 · Kezar Life Sciences, Inc. · Filed Jan 7, 2022
Insider Transaction Report
Form 4
Belsky Marc
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-05+140,000→ 140,000 totalExercise: $14.55Exp: 2032-01-04→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 5, 2022, subject to the Reporting Person continuing to provide service through each such date.